Long-term effects on corneal keratocytes of mitomycin C during photorefractive keratectomy: a randomized contralateral eye confocal microscopy study

J Refract Surg. 2007 Nov;23(9 Suppl):S1011-4. doi: 10.3928/1081-597X-20071102-06.

Abstract

Purpose: To evaluate the long-term side effects of mitomycin C (MMC) assisted photorefractive keratectomy (PRK) on corneal keratocytes of highly myopic eyes.

Methods: Twenty-eight patients with bilateral myopia from -7.00 to -14.25 diopters (D) underwent PRK on both eyes, one eye of each patient received topical application of 0.02% MMC for 2 minutes immediately after the PRK procedure. Corneal keratocyte density was quantified by corneal confocal microscopy at baseline and 5 years postoperatively.

Results: Photorefractive keratectomy reduced keratocyte density in the most anterior stromal layer, without a statistically significant difference between MMC and standard treated eyes. Posterior stromal layers showed no signs of keratocyte loss with either techniques.

Conclusions: Phototherapeutic keratectomy with 0.02% topical MMC has no significant side effects on corneal keratocytes compared to standard PRK, as documented by in vivo corneal confocal microscopy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Topical
  • Adult
  • Cell Count
  • Cornea / drug effects*
  • Cornea / pathology
  • Corneal Opacity / etiology
  • Corneal Opacity / prevention & control*
  • Double-Blind Method
  • Female
  • Humans
  • Lasers, Excimer
  • Longitudinal Studies
  • Male
  • Microscopy, Confocal
  • Middle Aged
  • Mitomycin / administration & dosage
  • Mitomycin / adverse effects*
  • Mitomycin / therapeutic use
  • Myopia / surgery
  • Nucleic Acid Synthesis Inhibitors / administration & dosage
  • Nucleic Acid Synthesis Inhibitors / adverse effects*
  • Nucleic Acid Synthesis Inhibitors / therapeutic use
  • Photorefractive Keratectomy / adverse effects*
  • Postoperative Care*

Substances

  • Nucleic Acid Synthesis Inhibitors
  • Mitomycin